Mokam Life Science Research Institute Holds '40th Anniversary' Commemorative Event

On the 9th and 10th of last month, Mokam Life Science Research Institute held a commemorative ceremony and symposium for its employees at the GC Green Cross R&D Center in Yongin, Gyeonggi Province, to celebrate its 40th anniversary, the institute announced on the 13th.

Director Kim Seon of Mokam Life Science Research Institute is delivering the 40th anniversary commemorative speech. [Photo by Mokam Life Science Research Institute]

Recognized as a pioneer in new drug development in the domestic pharmaceutical industry, Mokam Research Institute declared in 2022 its transformation into an artificial intelligence (AI)-based new drug development research institute, expanding its scope into various fields including messenger ribonucleic acid (mRNA) therapeutics development. In the mid to long term, it aims to develop an AI platform capable of simultaneously developing mRNA, protein modalities (therapeutic approaches), and small molecule compounds, actively collaborating with major domestic research institutions such as Seoul National University Hospital, Korea University, Seoul National University, and the Korea Advanced Institute of Science and Technology (KAIST).

In his founding anniversary speech, Director Kim Sun said, “With the advancement of AI technology, the paradigm of new drug development will be completely reorganized in the near future,” adding, “We will strive to become a pioneer in AI-based new drug development through collaboration with domestic and international scholars.”